News + Filings Holdings
|
Octagon Capital Advisors LP
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
Verona Pharma plc
| VRNA | SPONSORED ADS | 2,468,000 | 2,468,000 | 52,173,520,000 | 52,173,520,000 | 7.26 | |
Hist
| 06/30/2023 |
CymaBay Therapeutics, Inc.
| CBAY | Common | 4,570,918 | 4,570,918 | 50,051,552,000 | 50,051,552,000 | 6.96 | 4.70 |
Hist
| 06/30/2023 |
Roivant Sciences Ltd.
| ROIV | COM | 3,904,000 | 3,904,000 | 39,352,320,000 | 39,352,320,000 | 5.48 | |
Hist
| 06/30/2023 |
Mirati Therapeutics, Inc.
| MRTX | COM | 750,000 | 750,000 | 27,097,500,000 | 27,097,500,000 | 3.77 | 1.29 |
Hist
| 06/30/2023 |
Viridian Therapeutics, Inc.\DE
| VRDN | COM | 923,000 | 923,000 | 21,958,170,000 | 21,958,170,000 | 3.06 | 2.14 |
Hist
| 06/30/2023 |
89bio, Inc.
| ETNB | Common | 1,066,784 | 1,066,784 | 20,215,557,000 | 20,215,557,000 | 2.81 | |
Hist
| 06/30/2023 |
Disc Medicine, Inc.
| IRON | Common | 415,000 | 415,000 | 18,426,000,000 | 18,426,000,000 | 2.56 | 2.10 |
Hist
| 06/30/2023 |
Vir Biotechnology, Inc.
| VIR | Common | 650,100 | 650,100 | 15,946,953,000 | 15,946,953,000 | 2.22 | 0.49 |
Hist
| 06/30/2023 |
Reneo Pharmaceuticals, Inc.
| RPHM | Common | 2,368,587 | 2,368,587 | 15,537,931,000 | 15,537,931,000 | 2.16 | 7.04 |
Hist
| 06/30/2023 |
TANDEM DIABETES CARE INC
| TNDM | Common | 474,929 | 474,929 | 11,654,758,000 | 11,654,758,000 | 1.62 | 0.74 |
Hist
| 06/30/2023 |
Aerovate Therapeutics, Inc.
| AVTE | Common | 621,712 | 621,712 | 10,662,361,000 | 10,662,361,000 | 1.48 | |
Hist
| 06/30/2023 |
iTeos Therapeutics, Inc.
| ITOS | Common | 596,000 | 596,000 | 7,891,040,000 | 7,891,040,000 | 1.10 | 1.67 |
Hist
| 06/30/2023 |
Dyne Therapeutics, Inc.
| DYN | Common | 692,945 | 692,945 | 7,795,631,000 | 7,795,631,000 | 1.08 | 1.19 |
Hist
| 06/30/2023 |
INSMED Inc
| INSM | Common | 367,000 | 367,000 | 7,743,700,000 | 7,743,700,000 | 1.08 | 0.27 |
Hist
| 06/30/2023 |
ALPINE IMMUNE SCIENCES, INC.
| ALPN | Common | 750,000 | 750,000 | 7,710,000,000 | 7,710,000,000 | 1.07 | 1.56 |
Hist
| 06/30/2023 |
Travere Therapeutics, Inc.
| TVTX | Common | 495,000 | 495,000 | 7,603,200,000 | 7,603,200,000 | 1.06 | 0.76 |
Hist
| 06/30/2023 |
GERON CORP
| GERN | COM | 2,278,000 | 2,278,000 | 7,312,380,000 | 7,312,380,000 | 1.02 | 0.45 |
Hist
| 06/30/2023 |
Xilio Therapeutics, Inc.
| XLO | Common | 2,425,000 | 2,425,000 | 6,353,500,000 | 6,353,500,000 | 0.88 | 8.83 |
Hist
| 06/30/2023 |
AN2 Therapeutics, Inc.
| ANTX | Common | 720,900 | 720,900 | 6,127,650,000 | 6,127,650,000 | 0.85 | 3.71 |
Hist
| 06/30/2023 |
Jasper Therapeutics, Inc.
| JSPR | Common | 4,468,114 | 4,468,114 | 6,121,316,000 | 6,121,316,000 | 0.85 | 4.08 |
Hist
| 06/30/2023 |
Viking Therapeutics, Inc.
| VKTX | COM | 375,000 | 375,000 | 6,078,750,000 | 6,078,750,000 | 0.85 | |
Hist
| 06/30/2023 |
Annexon, Inc.
| ANNX | Common | 1,660,000 | 1,660,000 | 5,843,200,000 | 5,843,200,000 | 0.81 | 2.21 |
Hist
| 06/30/2023 |
GLYCOMIMETICS INC
| GLYC | COM | 3,000,000 | 3,000,000 | 5,220,000,000 | 5,220,000,000 | 0.73 | |
Hist
| 06/30/2023 |
LEXICON PHARMACEUTICALS, INC.
| LXRX | COM NEW | 1,923,076 | 1,923,076 | 4,403,844,000 | 4,403,844,000 | 0.61 | 1.02 |
Hist
| 06/30/2023 |
PMV Pharmaceuticals, Inc.
| PMVP | Common | 470,000 | 470,000 | 2,942,200,000 | 2,942,200,000 | 0.41 | 1.03 |
Hist
| 06/30/2023 |
Centessa Pharmaceuticals plc
| CNTA | SPONSORED ADS | 411,928 | 411,928 | 2,549,834,000 | 2,549,834,000 | 0.35 | |
Hist
| 06/30/2023 |
Oric Pharmaceuticals, Inc.
| ORIC | Common | 277,000 | 277,000 | 2,149,520,000 | 2,149,520,000 | 0.30 | 0.61 |
Hist
| 06/30/2023 |
IVERIC bio, Inc.
| ISEE | PUT | 50,000 | 50,000 | 1,967,000,000 | 1,967,000,000 | 0.27 | |
Hist
| 06/30/2023 |
Hepion Pharmaceuticals, Inc.
| HEPA | Stock | 155,000 | 155,000 | 1,627,500,000 | 1,627,500,000 | 0.23 | 4.07 |
Hist
| 06/30/2023 |
PIERIS PHARMACEUTICALS, INC.
| PIRS | COM | 6,600,000 | 6,600,000 | 1,092,300,000 | 1,092,300,000 | 0.15 | 8.05 |
Hist
| 06/30/2023 |
Magenta Therapeutics, Inc.
| MGTA | Common | 550,000 | 550,000 | 416,900,000 | 416,900,000 | 0.06 | 0.91 |
Hist
| 06/30/2023 |
Inozyme Pharma, Inc.
| INZY | Common | 49,702 | 49,702 | 276,840,000 | 276,840,000 | 0.04 | 0.11 |
Hist
| 06/30/2023 |
Monte Rosa Therapeutics, Inc.
| GLUE | Common | 19,900 | 19,900 | 136,315,000 | 136,315,000 | 0.02 | 0.04 |
Hist
| 06/30/2023 |
|
|
|
|